Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Ferrari

Showing results (181-190 of 246) with videos related to

Pageof 25
Sort By:
Cephalalgia : an International Journal of Headache|September 26, 2017
Chronotypes and circadian timing in migraineWpj van Oosterhout, Ejw van Someren, G G Schoonman, et al.
Cephalalgia : an International Journal of Headache|November 23, 2006
Chronic frequent headache in the general population: comorbidity and quality of lifeN J Wiendels, A van Haestregt, A Knuistingh Neven, et al.
Neurology|August 1, 1995
Oral sumatriptan in preventing headache recurrence after treatment of migraine attacks with subcutaneous sumatriptanA M Rapoport, W H Visser, N R Cutler, et al.
Cephalalgia : an International Journal of Headache|November 23, 2006
Chronic frequent headache in the general population: prevalence and associated factorsN J Wiendels, A Knuistingh Neven, F R Rosendaal, et al.
Neurology|June 17, 1999
Diagnostic Notch3 sequence analysis in CADASIL: three new mutations in Dutch patients. Dutch CADASIL Research GroupS A Oberstein, M D Ferrari, E Bakker, et al.
Cephalalgia : an International Journal of Headache|April 11, 2008
A gene for a new monogenic neurovascular migraine syndrome: a next step in unravelling molecular pathways for migraine?K R J Vanmolkot, G M Terwindt, R R Frants, et al.
Archives of Neurology|February 1, 1995
Cerebral blood flow during migraine attacks without aura and effect of sumatriptanM D Ferrari, J Haan, J A Blokland, et al.
Current Medical Research and Opinion|April 7, 2005
How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physiciansR B Lipton, F M Cutrer, P J Goadsby, et al.
Neurology|February 26, 2003
Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind studyJ A van Vliet, A Bahra, V Martin, et al.
Cephalalgia : an International Journal of Headache|May 20, 2011
Triptan overuse in the Dutch general population: a nationwide pharmaco-epidemiology database analysis in 6.7 million peopleF Dekker, N J Wiendels, V de Valk, et al.
Pageof 25

Showing results (181-190 of 246) with videos related to

Sort By:
Pageof 25
Cephalalgia : an International Journal of Headache|September 26, 2017
Chronotypes and circadian timing in migraineWpj van Oosterhout, Ejw van Someren, G G Schoonman, et al.
Cephalalgia : an International Journal of Headache|November 23, 2006
Chronic frequent headache in the general population: comorbidity and quality of lifeN J Wiendels, A van Haestregt, A Knuistingh Neven, et al.
Neurology|August 1, 1995
Oral sumatriptan in preventing headache recurrence after treatment of migraine attacks with subcutaneous sumatriptanA M Rapoport, W H Visser, N R Cutler, et al.
Cephalalgia : an International Journal of Headache|November 23, 2006
Chronic frequent headache in the general population: prevalence and associated factorsN J Wiendels, A Knuistingh Neven, F R Rosendaal, et al.
Neurology|June 17, 1999
Diagnostic Notch3 sequence analysis in CADASIL: three new mutations in Dutch patients. Dutch CADASIL Research GroupS A Oberstein, M D Ferrari, E Bakker, et al.
Cephalalgia : an International Journal of Headache|April 11, 2008
A gene for a new monogenic neurovascular migraine syndrome: a next step in unravelling molecular pathways for migraine?K R J Vanmolkot, G M Terwindt, R R Frants, et al.
Archives of Neurology|February 1, 1995
Cerebral blood flow during migraine attacks without aura and effect of sumatriptanM D Ferrari, J Haan, J A Blokland, et al.
Current Medical Research and Opinion|April 7, 2005
How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physiciansR B Lipton, F M Cutrer, P J Goadsby, et al.
Neurology|February 26, 2003
Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind studyJ A van Vliet, A Bahra, V Martin, et al.
Cephalalgia : an International Journal of Headache|May 20, 2011
Triptan overuse in the Dutch general population: a nationwide pharmaco-epidemiology database analysis in 6.7 million peopleF Dekker, N J Wiendels, V de Valk, et al.
Pageof 25